Company Filing History:
Years Active: 2007-2023
Title: The Innovative Mind of Yutaka Kataoka
Introduction
Yutaka Kataoka, an inventive genius based in Lindome, Sweden, has made significant contributions to the field of inhalation devices. With a remarkable portfolio of six patents, Kataoka continues to push the boundaries of innovation in respiratory health technology.
Latest Patents
Among his recent inventions is a sophisticated inhaler designed for facilitating the inhalation of dry powder medications. This device comprises a body that defines an interior space along with a mouthpiece. Within this space, at least one rotatable annular member holds multiple compartments, each designed to securely contain dry powder. The innovative design includes flaps that control the release of the powder, ensuring that it is dispensed only when required by the user.
Additionally, he developed a dose ring for dry powder inhaler (DPI) devices, which features an aluminum foil member designed to cover medication cavities and through holes. The ring incorporates hinged flaps, allowing easy access to medication while maintaining functionality.
Career Highlights
Yutaka Kataoka has demonstrated expertise and leadership through his tenure at esteemed companies such as Astra Tech AB and CSP Technologies, Inc. His work in these organizations has been pivotal in advancing inhalation technology, contributing to more effective delivery methods for dry powder medications.
Collaborations
Throughout his career, Kataoka has worked alongside distinguished colleagues, including Jean-Pierre Giraud and Bruce Rabinne. Their collaborative efforts have undoubtedly enriched the innovation landscape in the respiratory care sector.
Conclusion
Yutaka Kataoka's commitment to innovation in the field of inhalation devices stands as a testament to his dedication as an inventor. His patented technologies not only enhance patient care but also reflect the continuous evolution of respiratory health solutions. As he continues his journey, the impact of his inventions is sure to resonate across the medical community.